Alentis Therapeutics News and Activities
Presence
Headquarters: Switzerland
Acquisition, funding and merger involving Alentis Therapeutics.
- Alentis Therapeutics has just announced a $181 Million fundraising (posted on November 20 2024).
Executives
View the org chart displaying its 28 main executives
Most searched biographies at Alentis Therapeutics
- Mark Pruzanski, Chief Executive Officer
- Rafaèle Tordjman, Member of the Board
- William Pao, Independent Board Member
Popular executive movements at Alentis Therapeutics
- Bryan Yoon has joined the company as General Counsel and Chief Administrative Officer (posted on November 13 2025).
- Aditya Venugopal has joined the company as Chief Business Officer (posted on November 13 2025).
- Mark Pruzanski has joined the company as Chief Executive Officer (posted on October 16 2025).
Click here to view some more movements at Alentis Therapeutics
Create your alert
to follow the executive moves at Alentis Therapeutics.
Biotechnology
Alentis Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Alentis Therapeutics
Social media about Alentis Therapeutics
- Alentis Therapeutics on Wikipedia, Google News & Yahoo Finance
- Alentis Therapeutics on LinkedIn, X (Twitter) & YouTube
